These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 23781007)

  • 81. GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.
    Brockmann K; Srulijes K; Pflederer S; Hauser AK; Schulte C; Maetzler W; Gasser T; Berg D
    Mov Disord; 2015 Mar; 30(3):407-11. PubMed ID: 25448271
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.
    Di Lazzaro G; Ricci M; Al-Wardat M; Schirinzi T; Scalise S; Giannini F; Mercuri NB; Saggio G; Pisani A
    J Parkinsons Dis; 2020; 10(1):113-122. PubMed ID: 31594252
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.
    De Pablo-Fernandez E; Tur C; Revesz T; Lees AJ; Holton JL; Warner TT
    JAMA Neurol; 2017 Aug; 74(8):970-976. PubMed ID: 28655059
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dementia and survival in Parkinson disease: a 12-year population study.
    Buter TC; van den Hout A; Matthews FE; Larsen JP; Brayne C; Aarsland D
    Neurology; 2008 Mar; 70(13):1017-22. PubMed ID: 18362281
    [TBL] [Abstract][Full Text] [Related]  

  • 86. An Examination of Cognitive Heterogeneity in Parkinson Disease: The Dual-Syndrome Hypothesis.
    Summers D; Spencer K; Okasaki C; Huber JE
    J Speech Lang Hear Res; 2024 Apr; 67(4):1127-1135. PubMed ID: 38446552
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quantitative EEG as a predictive biomarker for Parkinson disease dementia.
    Klassen BT; Hentz JG; Shill HA; Driver-Dunckley E; Evidente VG; Sabbagh MN; Adler CH; Caviness JN
    Neurology; 2011 Jul; 77(2):118-24. PubMed ID: 21633128
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
    Hobson P; Meara J; Ishihara-Paul L
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    Wojtala J; Heber IA; Neuser P; Heller J; Kalbe E; Rehberg SP; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Dodel R; Schulz JB; Reetz K
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):171-179. PubMed ID: 30297519
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Parkinson's disease clinical milestones and mortality.
    Gonzalez MC; Dalen I; Maple-Grødem J; Tysnes OB; Alves G
    NPJ Parkinsons Dis; 2022 May; 8(1):58. PubMed ID: 35550520
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease.
    McGhee D; Parker A; Fielding S; Zajicek J; Counsell C
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):180-5. PubMed ID: 24854405
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort.
    Foltynie T; Matthews FE; Ishihara L; Brayne C;
    BMC Neurol; 2006 Aug; 6():29. PubMed ID: 16925826
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Early constipation predicts faster dementia onset in Parkinson's disease.
    Camacho M; Macleod AD; Maple-Grødem J; Evans JR; Breen DP; Cummins G; Wijeyekoon RS; Greenland JC; Alves G; Tysnes OB; Lawson RA; Barker RA; Williams-Gray CH
    NPJ Parkinsons Dis; 2021 May; 7(1):45. PubMed ID: 34039994
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association of Depression With Early Occurrence of Postural Instability in Parkinson's Disease.
    Hwang YS; Jo S; Park KW; Lee SH; Lee S; Chung SJ
    J Mov Disord; 2023 Jan; 16(1):68-78. PubMed ID: 36537065
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.
    Foltynie T; Brayne CE; Robbins TW; Barker RA
    Brain; 2004 Mar; 127(Pt 3):550-60. PubMed ID: 14691062
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Assessing the importance of primary care diagnoses in the UK Biobank.
    Clifton L; Liu X; Collister JA; Littlejohns TJ; Allen N; Hunter DJ
    Eur J Epidemiol; 2024 Feb; 39(2):219-229. PubMed ID: 38225527
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genetics in Parkinson's disease, state-of-the-art and future perspectives.
    Trevisan L; Gaudio A; Monfrini E; Avanzino L; Di Fonzo A; Mandich P
    Br Med Bull; 2024 Mar; 149(1):60-71. PubMed ID: 38282031
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Perceived imbalance and risk of Parkinson's disease.
    Gao X; Chen H; Schwarzschild MA; Logroscino G; Ascherio A
    Mov Disord; 2008 Mar; 23(4):613-6. PubMed ID: 18181208
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combining biomarkers for prognostic modelling of Parkinson's disease.
    Vijiaratnam N; Lawton M; Heslegrave AJ; Guo T; Tan M; Jabbari E; Real R; Woodside J; Grosset K; Chelban V; Athauda D; Girges C; Barker RA; Hardy J; Wood N; Houlden H; Williams N; Ben-Shlomo Y; Zetterberg H; Grosset DG; Foltynie T; Morris HR;
    J Neurol Neurosurg Psychiatry; 2022 May; 93(7):707-15. PubMed ID: 35577512
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up.
    Xie J; Brayne C; Matthews FE;
    BMJ; 2008 Feb; 336(7638):258-62. PubMed ID: 18187696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.